Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
出版年份 2019 全文链接
标题
Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
作者
关键词
-
出版物
MOLECULES
Volume 24, Issue 11, Pages 2152
出版商
MDPI AG
发表日期
2019-06-07
DOI
10.3390/molecules24112152
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells
- (2018) K. Čáňová et al. TOXICOLOGY IN VITRO
- Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
- (2018) Nilambra Dogra et al. Scientific Reports
- A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein
- (2017) Georgios Valianatos et al. PLoS One
- Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
- (2017) Farhad Ghasemi et al. Oncotarget
- The Roles of MDM2 and MDMX in Cancer
- (2016) Orit Karni-Schmidt et al. Annual Review of Pathology-Mechanisms of Disease
- Flubendazole induces mitotic catastrophe and senescence in colon cancer cellsin vitro
- (2016) Věra Králová et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Albendazole as a promising molecule for tumor control
- (2016) L.S.E.P.W. Castro et al. Redox Biology
- Potential Anti-cancer Drugs Commonly Used for Other Indications
- (2015) Veronika Hanusova et al. CURRENT CANCER DRUG TARGETS
- Exploration of Structure-Based on Imidazole Core as Antibacterial Agents
- (2013) Yong-Tao Duan et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling
- (2013) Brijal M. Desai et al. PLoS One
- Impairment of the Ubiquitin-Proteasome Pathway by MethylN-(6-Phenylsulfanyl-1H-benzimidazol-2-yl)carbamate Leads to a Potent Cytotoxic Effect in Tumor Cells
- (2012) Nilambra Dogra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status
- (2011) Jindřiška Hammerová et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Albendazole sensitizes cancer cells to ionizing radiation
- (2011) Kirtesh Patel et al. Radiation Oncology
- Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis
- (2010) Mohammad H. Pourgholami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazole
- (2010) Mohammad H Pourgholami et al. BMC CANCER
- Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells – Study of structure–activity relationship
- (2009) I. Slaninová et al. TOXICOLOGY IN VITRO
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
- (2008) N. Doudican et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now